Petco Health And Wellness Company, Inc. · NASDAQ:WOOF
Petco Health And Wellness — Q1 2025 Earnings Presentation
16 slides from Petco Health And Wellness's earnings presentation, Jun 5, 2025
Slide 1: First Quarter 2025 Earnings Call
First Quarter 2025 Earnings Call June 5, 2025
Slide 2: Safe Harbor and Non-GAAP Measures
Safe Harbor and Non-GAAP Measures This Presentation contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 as contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amend
Slide 3: Key Takeaways
First Quarter Key Takeaways Delivered Q1 earnings ahead of expectations as efforts to strengthen retail fundamentals begin to take hold ➢ Adj. EBITDA1 increased $13.8M to $89.4M ahead of prior outlook Focused on core tenets of economic model to expand gross margin, leverage SG&A and prioritize ROIC
Slide 4: Executing Against Priorities in 2025
Q2 and Full Executing Year 2025 Against Guidance Priorities in 2025 Phase 1 – Strengthening Fundamentals ➢ Strengthening retail fundamentals ➢ Completed build out of senior leadership team with proven retail executives Phase 2 – Implementing and Executing ➢ Continued progress on improving retail fun
Slide 5: Economic Model
Economic Model Expand gross margin rate Our number-one financial priority is clear: Leverage expenses through operational excellence & renewed cost restoring the health of our economic model which, in turn, will improve our earnings discipline power and set the foundation for sustainable, profitable
Slide 6: Q1 2025 Net Sales Performance
Q1 2025 Net Sales Performance NET SALES BY CATEGORY ($ in millions) Net Sales Overview $1,529 $1,524 $1,511 $1,552 $1,493 249 260 242 Services and Other 248 252 ➢ Services and Other continues to deliver positive net sales growth 516 510 529 Supplies and CA 519 494 ➢ Consumables net sales declined (2
Slide 7: Q1 2025 Results
Q1 2025 Results ADJUSTED EBITDA1 ($ in millions) $89 $76 Q1'24 Q1'25 Adj. EBITDA Margin1 4.9% 6.0% NET DEBT1 & LIQUIDITY 2 FREE CASH FLOW1 ($ in millions) Q1’24 Q1’25 YoY % Change $(41) $(44) Net Debt1 $1.50B $1.46B (2)% Liquidity2 $617M $648M 5% YTD'24 YTD'25 (1) Non-GAAP financial measure; see def
Slide 8: Q2 and Full Year 2025 Guidance
Q2 and Full Year 2025 Guidance Q2 2025 Guidance2 Full Year 2025 Guidance2 Net sales Down low single digits y/y Net sales Down low single digits y/y Adjusted EBITDA1 $375M to $390M Adjusted EBITDA1 $92M to $94M Net interest expense ~$130M Capital expenditures ~$125M to $130M Depreciation and Amortiza
Slide 9: Non-GAAP Measures and Other Definitions
Non-GAAP Measure and Other Definitions
Slide 10: Non-GAAP Measures and Other Definitions
Non-GAAP Measures and Other Definitions The following information provides definitions and reconciliations of the non-GAAP financial measures presented in this Presentation to the most directly comparable financial measures calculated and presented in accordance with U.S. generally accepted accounti
Slide 11: Non-GAAP Measures: Adjusted EBITDA
Non-GAAP Measures: Adjusted EBITDA* (dollars in thousands) 13 Weeks Ended Reconciliation of Net Loss Attributable to Class A and B-1 May 3, May 4, Common Stockholders to Adjusted EBITDA 2025 2024 Net loss attributable to Class A and B-1 common stockholders $ (11,661) $ (46,483) Add (deduct): Interes
Slide 12: Non-GAAP Measures: Free Cash Flow
Non-GAAP Measures: Free Cash Flow (in thousands) 13 Weeks Ended May 3, May 4, 2025 2024 Net cash used in operating activities $ (15,454) $ (8,414) Cash paid for fixed assets (28,412) (32,641) Free Cash Flow $ (43,866) $ (41,055) 12
Slide 13: Non-GAAP Measures: Net Debt
Non-GAAP Measures: Net Debt 13
Slide 14: Net Sales by Category
Net Sales by Category ee 13 Weeks Ended May 3, May 4, April 29, % Change % Change 2025 2024 2023 (tyr) (2yr) Consumables $ 748,070 $ 763,974 $ 763,051 (2%) (2%) Supplies and companion animals 493,821 515,757 553,545 (4%) (11%) Services and other 251,508 249,409 239,312 1% 5% Net sales $1,493,399 $1,
Slide 15: Non-GAAP Financial Measures' Footnotes
Non-GAAP Financial Measures’ Footnotes (1) Mexico Joint Venture EBITDA represents 50 percent of the entity’s operating results for all periods, as adjusted to reflect the results on a basis comparable to Adjusted EBITDA. In the financial statements, this joint venture is accounted for as an equity m
Slide 16: Thank You
Thank You ©2025 Petco Health and Wellness Company, Inc.
Petco Health and Wellness Company — Q1 2025 Earnings Presentation on 6ix